Key Points Industry and Company Overview 1. **Industry Leader**: Thermo Fisher Scientific is a global leader in life science tools and diagnostics, often considered the industry's state of the state [4]. 2. **Market Conditions**: The industry experienced improving market conditions throughout the year, with businesses and end markets being predictable [6]. 3. **Share Gain Momentum**: Despite market volatility, Thermo Fisher has continued to gain market share and raise EPS consistently [6]. Election and Industry Impact 1. **Rebalancing of Portfolios**: The election and uncertainty around HHS policy led to a rebalancing of portfolios outside of the space [16]. 2. **Business-Friendly Administration**: A more business-friendly administration is expected to benefit the industry and Thermo Fisher's business [17]. 3. **NIH Exposure**: Thermo Fisher has a low exposure to NIH funding, with approximately 7-8% of revenue indirectly affected [24]. Pharma and Biotech 1. **Market Improvement**: Pharma and biotech markets are slowly improving, with activity picking up and pipelines strengthening [47]. 2. **Investment in R&D**: Thermo Fisher has continued to invest heavily in R&D, leading to the launch of innovative products like the Astral mass spectrometer [52]. 3. **Share Gain**: Thermo Fisher has gained share in the analytical instruments segment, particularly in areas like cryo EM and separation analysis [51]. M&A and Capital Deployment 1. **M&A Environment**: Thermo Fisher is optimistic about the M&A environment, with more unknowns creating opportunities for transactions [38]. 2. **Capital Deployment**: Thermo Fisher has a long-standing capital deployment strategy, with approximately 1/3 of deployed capital allocated to share buybacks and dividends [43]. 3. **Recent Buyback**: Thermo Fisher authorized a $4 billion share buyback in September 2024 [43]. 2025 Outlook 1. **Pandemic-Related Activity**: The headwind of pandemic-related activity will be significantly reduced in 2025 [64]. 2. **Share Gain Momentum**: Thermo Fisher expects to maintain strong share gain momentum in 2025, driven by new contracts and a better track record of navigating volatility [68]. 3. **Long-Term Misconceptions**: The biggest misconception is that Thermo Fisher cannot consistently grow share, despite its clear strategy and strong earnings growth [70].

Datadog, Inc. (NASDAQ:DDOG) RBC Capital Markets Global TIMT Conference November 19, 2024 10:00 AM ET Company Participants David Obstler - CFO Conference Call Participants Matthew Hedberg - RBC Capital Markets Matthew Hedberg My name is Matt Hedberg. Thank you. By the way, I got a pause for a second. You guys make this -- this conference is fantastic. Like I was talking to Matt Finigan who runs sales, like you can't even hardly walk in the hallways, it's just it's great attendance. And so you guys make this ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stifel 2024 Healthcare Conference November 19, 2024 8:00 AM ET Company Participants Stuart Arbuckle - EVP, COO Conference Call Participants Paul Matteis - Stifel Paul Matteis Great, good morning. It's my pleasure to be moderating this chat with Stuart Arbuckle, COO of Vertex Pharmaceuticals. Good to see you again. We had a nice dinner last night. Stuart Arbuckle We did. Question-and-Answer Session Q - Paul Matteis Maybe to start, Stuart, I think we can have ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Jefferies London Healthcare Conference November 19, 2024 3:30 AM ET Company Participants Richard Francis - President & CEO Conference Call Participants Glen Santangelo - Jefferies Glen Santangelo Good morning, everyone. Thanks for joining us. For those of you who don't know me, I'm Glen Santangelo. I'm the Spec Pharm Analyst at Jefferies, and cover Teva amongst some other things. And we're very excited to be hosting, Teva, and to my right, the CEO of the Co ...

Prices may vary in areas outside metABCD ropolitan Washington. ESu V1 V2 V3 V4 Democracy Dies in Darkness monday, november 18, 2024 . Partly sunny 71/50 • Tomorrow: Partly sunny 65/52 B6 $3 PhoToS by ilan godfrey for The WaShingTon PoST community members from kanyelele town, zambia, swim on the banks of the lake created by the kariba Dam. Zambia's green energy is running dry Hydropower had long provided cheap, clean power — until drought set in For a while, it looked like Zambia had achieved a status that a ...

C DOW JONES Investors Are Betting On Market Melt-Up A Developer's Rise To Mideast Envoy ****** MONDAY, NOVEMBER 18, 2024 ~ VOL. CCLXXXIV NO. 119 WSJ.com HHHH $5.00 Last week: DJIA 43444.99 g 544.00 1.24% NASDAQ 18680.12 g 3.1% STOXX 600 503.12 g 0.7% 10-YR. TREASURY g 30/32 , yield 4.426% OIL $67.02 g $3.36 EURO $1.0541 YEN 154.34 Business & Finance Many investors are betting the U.S. stock-market rally has room to run, signaling their optimism by pouring money into exchangetraded and mutual funds. A1 Toy m ...

14 Nov 2024 11:22:53 ET │ 11 pages China Battery Materials Takeaways from Battery Expert Call with GGII CITI'S TAKE We hosted a battery expert call on 14th Nov with Mr. HU Feng, chief analyst at GGII, who shared his take on the lithium-ion battery market. He expects EV battery demand to reach 900-950GWh and ESS demand to reach 350-400Gwh in 2025E. The expert call was conducted in Mandarin and below are our key takeaways. We believe we are at the trough of the battery cycle (see our notes part 1 and part 2). ...

14 Nov 2024 09:32:57 ET │ 10 pages China Materials 2024 On-ground Demand Monitor Series #136 – Aluminum Inventory and Consumption CITI'S TAKE In this series of notes, we aim to track and analyze high-frequency onground demand trends in China – market expectation on demand recovery has been largely cautious. In this note, we enclose weekly data from Mysteel, a consultant, on China aluminum ingot and billet production, inventory, and apparent consumption data during the week of 7th to 13th Nov. We shift our n ...

Summary of the Conference Call on China Auto Manufacturers Industry Overview - The report focuses on the **China Auto Manufacturers** industry, specifically the performance of imported vehicle sales in October 2024 and the year-to-date figures for 2024. Key Points 1. **Imported Vehicle Sales Performance** - October 2024 retail sales of imported vehicles decreased by **20% YoY** and **7% MoM**, totaling **48.5k units** sold. - Year-to-date (10M24) imported car retail sales were down **14% YoY**, amounting to **531.0k units** sold. [1][2][7] 2. **Brand-Specific Sales Data** - **Mercedes-Benz**: Sold **10,724 units** in October 2024, down **5% YoY** and **10% MoM**. Year-to-date sales decreased by **18%** to **105,204 units**. - **BMW**: Sales fell **36% YoY** to **4,990 units** in October, with a **18%** decline in year-to-date sales. - **Porsche**: Experienced a **32% YoY** drop, selling **3,618 units** in October, and a **33%** decline year-to-date. - **Audi**: Sales decreased by **29% YoY** to **3,412 units** in October, with a **15%** decline year-to-date. - **Land Rover**: Notably down **89% YoY** in October, selling **3,531 units**. - **Toyota**: Sales decreased by **27% YoY** to **2,333 units** in October, but year-to-date sales increased by **8%**. - **Other Brands**: Significant declines were noted across various brands, with total import passenger vehicle sales down **20% YoY** in October. [2][7] 3. **Investment Ratings** - **ZSG (0881.HK)**: Target price raised to **HK$23.25** based on a **6x 2026E P/E** multiple, reflecting sector downcycle and earnings improvement trajectory. - **Yongda (3669.HK)**: Target price set at **HK$2.98**, with a projected **8% dividend yield** for 2024. - **Meidong Auto (1268.HK)**: Target price of **HK$2.40**, with a focus on cash flow and healthy inventory management. [9][12][13] 4. **Risks Identified** - **Macroeconomic Weakness**: A weak macro environment could reduce consumer purchasing power, especially in lower-tier cities. - **Revenue and Margin Risks**: Lower-than-expected revenues and gross profit margins in the passenger vehicle and after-sales businesses could impact performance. - **Intensified Competition**: Increased competition may pressure profitability. - **Sales and Earnings Risks**: Risks associated with actual sales and earnings performance, particularly if a post-pandemic rebound does not occur as anticipated. [10][11][14] 5. **Analyst Insights** - Analysts express caution regarding the overall market conditions and the potential for continued declines in sales across various brands. The focus remains on identifying companies with strong management and prudent expansion strategies to navigate the current downcycle. [4][10][11] Additional Important Information - The report includes detailed sales figures by brand and highlights the significant declines in the luxury vehicle segment. - Analysts emphasize the importance of monitoring macroeconomic indicators and consumer sentiment as key factors influencing the auto industry in China. - The report also discusses the potential for dealer consolidation in the medium term, which could impact market dynamics. [1][2][9][10]

Industry Overview * **Industrial Production**: Industrial production fell 0.3% MoM in October, slightly stronger than consensus expectations at -0.4%. The largest subset of manufacturing production declined 0.5% MoM. * **Temporary Factors**: The Federal Reserve indicated a 0.3pp drag from strikes and hurricanes during the month. These factors should rebound and boost IP in November. * **Underlying Trend**: The underlying trend of manufacturing activity remains subdued even without these temporary factors. * **Near-term Outlook**: The near-term outlook remains unclear. There could be some boost to activity from lifting of post-election uncertainty, but recently rising yields could weigh further on this ratesensitive sector. * **Survey Data**: Citi will be watching survey data like ISM manufacturing for any change in the outlook for still-soft underlying activity. Key Points * **Industrial Production**: Industrial production fell 0.3% MoM in October, slightly stronger than consensus expectations at -0.4% and Citi at -0.7% [6]. * **Temporary Factors**: The Federal Reserve indicated a 0.3pp drag from strikes and hurricanes during the month. These factors should rebound and boost IP in November [1]. * **Underlying Trend**: The underlying trend of manufacturing activity remains subdued even without these temporary factors [1]. * **Near-term Outlook**: The near-term outlook remains unclear. There could be some boost to activity from lifting of post-election uncertainty, but recently rising yields could weigh further on this ratesensitive sector [1]. * **Survey Data**: Citi will be watching survey data like ISM manufacturing for any change in the outlook for still-soft underlying activity [1].